By 2018, China's Ophthalmic Medicine Market Will Exceed 30 Billion Yuan

- Jun 14, 2018-

On December 28th, familiar drug firms in one hundred, chongqing kerui pharmaceutical, hand in hand to the Japanese ancient pharmaceutical to build chongqing towering kerui pharmaceutical co., LTD., ma liu development zone in chongqing C28 land based. It will be the largest production base of ophthalmic medicine in China. Vice director of chongqing economic and information technology commission, vice chairman of the CPPCC of banan district, executive officer of Japan shentian group and minister of Asian affairs satoshi suzuki attended the ceremony. In chorus music and salute, the relevant leaders and guests, common symbol for chongqing towering kerui pharmaceutical co., LTD., the image of the eye shape ice sculptures, into the blue liquid, to open the bright future of the company. Then everyone prepared an important shovel of earth for the foundation stone, and the scene was jubilant. Located in chongqing hemp C28 plot willow development zone, the towering kerui pharmaceutical co., LTD., will be in accordance with the strict requirements of high quality design and construction, as China's largest ophthalmic drug production base, the two sides work together to patients in China continue to supply high quality and reasonable price of drug treatment. In the future, citizens will be able to enjoy eye preparations from Japan's top technology without leaving chongqing.